Merck’s Molnupiravir Open License With Medicines Patent Pool May Be Model

 
• By Brenda Sandburg
Molnupiravir
Merck licenses its COVID-19 drug molnupiravir to the Medicines Patent Pool • Source: Alamy

More from Legal & IP

More from Pink Sheet